ArticleEndocrine2021

Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study.

Martyn E Caplin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.